Cargando…
Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find pred...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278662/ https://www.ncbi.nlm.nih.gov/pubmed/21657974 http://dx.doi.org/10.3109/17453674.2011.590761 |
_version_ | 1782223602198773760 |
---|---|
author | Crnalic, Sead Hildingsson, Christer Wikström, Pernilla Bergh, Anders Löfvenberg, Richard Widmark, Anders |
author_facet | Crnalic, Sead Hildingsson, Christer Wikström, Pernilla Bergh, Anders Löfvenberg, Richard Widmark, Anders |
author_sort | Crnalic, Sead |
collection | PubMed |
description | BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find predictors of survival. PATIENTS AND METHODS: We reviewed the records of 54 consecutive patients with metastatic prostate cancer who were operated for spinal cord compression at Umeå University Hospital. The indication for surgery was neurological deficit due to spinal cord compression. 41 patients had hormone-refractory cancer and 13 patients had previously untreated, hormone-naïve prostate cancer. 29 patients were operated with posterior decompression only, and in 25 patients posterior decompression and stabilization was performed. RESULTS: Preoperatively, 6/54 of patients were able to walk. 1 month after surgery, 33 patients were walking, 15 were non-ambulatory, and 6 had died. Mortality rate was 11% at 1 month, 41% at 6 months, and 59% at 1 year. In the hormone-naïve group, 8/13 patients were still alive with a median postoperative follow-up of 26 months. In the hormone-refractory group, median survival was 5 months. Patients with hormone-refractory disease and Karnofsky performance status (KPS) of ≤ 60% had median survival of 2.5 months, whereas those with KPS of 70% and KPS of ≥ 80% had a median survival of 7 months and 18 months, respectively (p < 0.001). Visceral metastases were present in 12/41 patients with hormone-refractory tumor at the time of spinal surgery, and their median survival was 4 months—as compared to 10 months in patients without visceral metastases (p = 0.003). Complications within 30 days of surgery occurred in 19/54 patients. INTERPRETATION: Our results indicate that patients with hormone-naive disease, and those with hormone-refractory disease with good performance status and lacking visceral metastases, may be helped by surgery for metastatic spinal cord compression. |
format | Online Article Text |
id | pubmed-3278662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Informa Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-32786622012-02-15 Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer Crnalic, Sead Hildingsson, Christer Wikström, Pernilla Bergh, Anders Löfvenberg, Richard Widmark, Anders Acta Orthop Article BACKGROUND AND PURPOSE: The criteria for selecting patients who may benefit from surgery of spinal cord compression in metastatic prostate cancer are poorly defined. We therefore studied patients operated for metastatic spinal cord compression in order to evaluate outcome of surgery and to find predictors of survival. PATIENTS AND METHODS: We reviewed the records of 54 consecutive patients with metastatic prostate cancer who were operated for spinal cord compression at Umeå University Hospital. The indication for surgery was neurological deficit due to spinal cord compression. 41 patients had hormone-refractory cancer and 13 patients had previously untreated, hormone-naïve prostate cancer. 29 patients were operated with posterior decompression only, and in 25 patients posterior decompression and stabilization was performed. RESULTS: Preoperatively, 6/54 of patients were able to walk. 1 month after surgery, 33 patients were walking, 15 were non-ambulatory, and 6 had died. Mortality rate was 11% at 1 month, 41% at 6 months, and 59% at 1 year. In the hormone-naïve group, 8/13 patients were still alive with a median postoperative follow-up of 26 months. In the hormone-refractory group, median survival was 5 months. Patients with hormone-refractory disease and Karnofsky performance status (KPS) of ≤ 60% had median survival of 2.5 months, whereas those with KPS of 70% and KPS of ≥ 80% had a median survival of 7 months and 18 months, respectively (p < 0.001). Visceral metastases were present in 12/41 patients with hormone-refractory tumor at the time of spinal surgery, and their median survival was 4 months—as compared to 10 months in patients without visceral metastases (p = 0.003). Complications within 30 days of surgery occurred in 19/54 patients. INTERPRETATION: Our results indicate that patients with hormone-naive disease, and those with hormone-refractory disease with good performance status and lacking visceral metastases, may be helped by surgery for metastatic spinal cord compression. Informa Healthcare 2012-02 2012-02-08 /pmc/articles/PMC3278662/ /pubmed/21657974 http://dx.doi.org/10.3109/17453674.2011.590761 Text en Copyright: © Nordic Orthopaedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited. |
spellingShingle | Article Crnalic, Sead Hildingsson, Christer Wikström, Pernilla Bergh, Anders Löfvenberg, Richard Widmark, Anders Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title | Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title_full | Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title_fullStr | Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title_full_unstemmed | Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title_short | Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
title_sort | outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278662/ https://www.ncbi.nlm.nih.gov/pubmed/21657974 http://dx.doi.org/10.3109/17453674.2011.590761 |
work_keys_str_mv | AT crnalicsead outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer AT hildingssonchrister outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer AT wikstrompernilla outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer AT berghanders outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer AT lofvenbergrichard outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer AT widmarkanders outcomeaftersurgeryformetastaticspinalcordcompressionin54patientswithprostatecancer |